Micro Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
|
SBFM
26
Sunshine Biopharma
SBFM
$4.42M
| $4.42M | $1.14 | 1.72% |
|
|
RDHL
27
Redhill Biopharma
RDHL
$3.68M
| $3.68M | $0.6051 | 0.02% |
|
28
Universe Pharmaceuticals Inc
UPC
$3.26M
| $3.26M | $5.03 | 6.16% |
|
29
PRF Technologies Ltd
PRFX
$3.03M
| $3.03M | $0.9948 | 1.5% |
|
30
Akanda
AKAN
$2.68M
| $2.68M | $4.95 | 33.4% |
|
31
Shuttle Pharmaceuticals
SHPH
$2.01M
| $2.01M | $3.44 | 2.27% |
|
32
China SXT Pharmaceuticals
SXTC
$1.91M
| $1.91M | $3.58 | 5.79% |
|
|
IMCC
33
IM Cannabis
IMCC
$1.77M
| $1.77M | $0.1088 | 0.64% |
|
Micro Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 33 micro cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap under $250M — worth a combined $2.13B.
The largest by market cap are Cardiol Therapeutics (CRDL) at $234M, Organogenesis Holdings (ORGO) at $224M and SIGA Technologies (SIGA) at $218M.
Among institutional investors, Organogenesis Holdings (ORGO) drew the most net new fund positions in Q2 2026: 31 funds opened new positions, taking total fund holders up 14 (12%) quarter-over-quarter.
- Combined market cap: $2.13B across 33 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Cardiol Therapeutics (CRDL), $234M market cap.
- Most net new fund positions in Q2 2026: Organogenesis Holdings (ORGO), +14 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.